Literature DB >> 12406322

Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6.

Takahiro Watanabe1, Tatsuyoshi Kawamura, Sharon E Jacob, Elisabeth A Aquilino, Jan M Orenstein, Jodi B Black, Andrew Blauvelt.   

Abstract

Pityriasis rosea is a common skin disease that has been suspected to have a viral etiology. We performed nested polymerase chain reaction to detect human herpesvirus-7, human herpesvirus-6, and cytomegalovirus DNA in lesional skin, nonlesional skin, peripheral blood mononuclear cells, serum, and saliva samples isolated from 14 pityriasis rosea patients. Viral mRNA expression and virion visualization within lesional skin were studied by in situ hybridization and transmission electron microscopy, respectively. By nested polymerase chain reaction, human herpesvirus-7 DNA was present in lesional skin (93%), nonlesional skin (86%), saliva (100%), peripheral blood mononuclear cells (83%), and serum (100%) samples, whereas human herpesvirus-6 DNA was detected in lesional skin (86%), nonlesional skin (79%), saliva (80%), peripheral blood mononuclear cells (83%), and serum (88%) samples. By contrast, cytomegalovirus DNA was not detected in these tissues. Control samples from 12 healthy volunteers and 10 psoriasis patients demonstrated rare positivity for either human herpesvirus-7 or human herpesvirus-6 DNA in skin or serum. By in situ hybridization, infiltrating mononuclear cells expressing human herpesvirus-7 and human herpesvirus-6 mRNA were identified in perivascular and periappendageal areas in 100% and 75% pityriasis rosea skin lesions, respectively, compared to herpesviral mRNA positivity in only 13% normal skin and psoriasis skin controls. Transmission electron microscopy failed to reveal herpesviral virions in pityriasis rosea lesional skin. Nested polymerase chain reaction and in situ hybridization enabled detection of human herpesvirus-7 and human herpesvirus-6 in skin and other tissues isolated from patients with pityriasis rosea. These results suggest that pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406322     DOI: 10.1046/j.1523-1747.2002.00200.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  35 in total

1.  [Pityriasis rosea. Reactivation of human Herpesvirus 6 and 7 infection?].

Authors:  B Korge
Journal:  Hautarzt       Date:  2002-12-21       Impact factor: 0.751

2.  [Unusual combination of clinical forms in a young man. Atypical pityriasis rosea].

Authors:  D Meyersburg; H P Bertsch; C Neumann
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

Review 3.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

4.  Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.

Authors:  Malak M Alame; Dina J Chamsy; Hassan Zaraket
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

5.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

6.  Concurrent pityriasis rosea and Bell's palsy.

Authors:  Vanessa Voss; Adam Mattox; Mary Guo
Journal:  BMJ Case Rep       Date:  2017-01-23

7.  The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.

Authors:  Amirhooshang Ehsani; Nafiseh Esmaily; Pedram Noormohammadpour; Siavash Toosi; Alireza Hosseinpour; Mahbobeh Hosseini; Shima Sayanjali
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

8.  A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea.

Authors:  Satyaki Ganguly
Journal:  J Clin Diagn Res       Date:  2014-05-15

9.  Pityriasis rosea like drug rash - a need to identify the disease in childhood.

Authors:  Maitreyee Panda; Nibedita Patro; Monalisa Jena; Mrutunjay Dash; Swati Mishra
Journal:  J Clin Diagn Res       Date:  2014-08-20

10.  Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.

Authors:  J M Busto-Leis; G Servera-Negre; A Mayor-Ibarguren; E Sendagorta-Cudós; M Feito-Rodríguez; A Nuño-González; M D Montero-Vega; P Herranz-Pinto
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-12       Impact factor: 9.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.